MYLAN-CIPROFLOXACIN XL DIN 02416484
Status: Cancelled Pre Market
Holder: MYLAN PHARMACEUTICALS ULC
Health Canada record
| Active ingredient(s) | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN) 1000 MG |
|---|---|
| Dosage form | Tablet (Extended-Release) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01MA02 CIPROFLOXACIN |
| Original market date | |
| Current status date | 02-Nov-2016 |
| Source | Health Canada DPD |
Establishment licence of the holder
Mylan Pharmaceuticals ULC — licence 101774, currently licensed, last inspection rating C (2026-02-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02247916 | CIPRO XL | BAYER INC | Tablet (Immediate- And Extended-Release) | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN) 500 MG | Cancelled Post Market |
| 02416433 | PMS-CIPROFLOXACIN XL | PHARMASCIENCE INC | Tablet (Immediate- And Extended-Release) | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN) 500 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 14996 | 2013-12-09 | Abbreviated New Drug Submission (ANDS) |